The degree of tumor volume reduction during the early phase of induction chemotherapy is an independent prognostic factor in patients with high-risk neuroblastoma-Reference-Cited by-同舟云学术

The degree of tumor volume reduction during the early phase of induction chemotherapy is an independent prognostic factor in patients with high-risk neuroblastoma

Published:2012-09-05 Issue:3 Volume:119 Page:656-664
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Yoo So Young,Kim Jung-Sun,Sung Ki Woong,Jeon Tae Yeon,Choi Joon Young,Moon Seung Hwan,Son Meong Hi,Lee Soo Hyun,Yoo Keon Hee,Koo Hong Hoe

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.27775/fullpdf

Reference25 articles.

1. Early response to therapy and outcome in childhood acute lymphoblastic leukemia: a review;Gaynon;Cancer.,1997

2. Cytoreduction and prognosis in acute lymphoblastic leukemia-the importance of early marrow response: report from the Children's Cancer Group;Steinherz;J Clin Oncol.,1996

3. Persistence of circulating blasts after 1 week of multiagent chemotherapy confers a poor prognosis in childhood acute lymphoblastic leukemia;Gajjar;Blood.,1995

4. Early blast clearance by remission induction therapy is a major independent prognostic factor for both achievement of complete remission and long-term outcome in acute myeloid leukemia: data from the German AML Cooperative Group (AMLCG) 1992 Trial;Kern;Blood.,2003

5. Grade of chemotherapy-induced necrosis as a predictor of local and systemic control in 881 patients with non-metastatic osteosarcoma of the extremities treated with neoadjuvant chemotherapy in a single institution;Bacci;Eur J Cancer.,2005

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Response‐adapted consolidation therapy strategy for patients with metastatic high‐risk neuroblastoma: Results of the SMC NB‐2014 study;Pediatric Blood & Cancer;2024-07-04

2. A narrative review of radiomics and deep learning advances in neuroblastoma: updates and challenges;Pediatric Radiology;2023-11-10

3. Contrast-enhanced computed tomography radiomics in predicting primary site response to neoadjuvant chemotherapy in high-risk neuroblastoma;Abdominal Radiology;2022-12-26

4. Induction Regimen in High-Risk Neuroblastoma: A Pilot Study of Highly Effective Continuous Exposure of Tumor Cells to Radio-Chemotherapy Sequence for 1 Month. The Critical Role of Iodine-131-Metaiodobenzylguanidine;Cancers;2022-10-21

5. Semi-Automatic Volumetric and Standard Three-Dimensional Measurements for Primary Tumor Evaluation and Response to Treatment Assessment in Pediatric Rhabdomyosarcoma;Journal of Personalized Medicine;2021-07-26